Provectus Biopharmaceuticals, Inc. (PVCT)

PVCT Revenue

Provectus Biopharmaceuticals had revenue of $590.76K in the twelve months ending March 31, 2024, down -41.30% year-over-year. Revenue in the quarter ending March 31, 2024 was $238.07K with 16.12% year-over-year growth. In the year 2023, Provectus Biopharmaceuticals had annual revenue of $557.71K, a decrease of -43.61%.

• Revenue (ttm): $590.76K
• Revenue Growth: -41.30%
• P/S Ratio: 88.41
• Revenue / Employee: $147,689
• Employees: 4
• Market Cap: 52.23M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	557.71K	-431.33K	-43.61%
Dec 31, 2022	989.04K	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	4.18M	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	9.76B	-	-
Dec 31, 2010	0	-	-
Dec 31, 2009	0	-	-
Dec 31, 2008	0	-	-
Dec 31, 2007	0	-	-
Dec 31, 2006	1.37K	-5.17K	-79.07%
Dec 31, 2005	6.54K	-25.32K	-79.48%
Dec 31, 2004	31.85K	-	-
Dec 31, 2003	0	-	-
Dec 31, 2002	0	-	-
Dec 31, 2001	0	-	-
Dec 31, 2000	1.00	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.